Literature DB >> 35904198

Cardiac Comorbidity Risk Score: Zero-Burden Machine Learning to Improve Prediction of Postoperative Major Adverse Cardiac Events in Hip and Knee Arthroplasty.

Dmytro Onishchenko1, Daniel S Rubin2, James R van Horne3, R Parker Ward1,4, Ishanu Chattopadhyay1,5,6,7.   

Abstract

Background In this retrospective, observational study we introduce the Cardiac Comorbidity Risk Score, predicting perioperative major adverse cardiac events (MACE) after elective hip and knee arthroplasty. MACE is a rare but important driver of mortality, and existing tools, eg, the Revised Cardiac Risk Index demonstrate only modest accuracy. We demonstrate an artificial intelligence-based approach to identify patients at high risk of MACE within 4 weeks (primary outcome) of arthroplasty, that imposes zero additional burden of cost/resources. Methods and Results Cardiac Comorbidity Risk Score calculation uses novel machine learning to estimate MACE risk from patient electronic health records, without requiring blood work or access to any demographic data beyond that of sex and age, and accounts for variable/missing/incomplete information across patient records. Validated on a deidentified cohort (age >45 years, n=445 391), performance was evaluated using the area under the receiver operator characteristics curve (AUROC), sensitivity/specificity, positive predictive value, and positive/negative likelihood ratios. In our cohort (age 63.5±10.5 years, 58.2% women, 34.2%/65.8% hip/knee procedures), 0.19% (882) experienced the primary outcome. Cardiac Comorbidity Risk Score achieved area under the receiver operator characteristics curve=80.0±0.4% (95% CI) for women and 80.1±0.5% (95% CI) for males, with 36.4% and 35.1% sensitivities, respectively, at 95% specificity, significantly outperforming Revised Cardiac Risk Index across all studied age-, sex-, risk-, and comorbidity-based subgroups. Conclusions Cardiac Comorbidity Risk Score, a novel artificial intelligence-based screening tool using known and unknown comorbidity patterns, outperforms state-of-the-art in predicting MACE within 4 weeks postarthroplasty, and can identify patients at high risk that do not demonstrate traditional risk factors.

Entities:  

Keywords:  Revised Cardiac Risk Index; hip and knee arthroplasty; machine learning; risk of MACE

Mesh:

Year:  2022        PMID: 35904198      PMCID: PMC9375497          DOI: 10.1161/JAHA.121.023745

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   6.106


  43 in total

1.  Differences in the views of orthopaedic surgeons and referring practitioners on the determinants of outcome after total hip replacement.

Authors:  T Stürmer; K Dreinhöfer; D Gröber-Grätz; H Brenner; P Dieppe; W Puhl; K-P Günther
Journal:  J Bone Joint Surg Br       Date:  2005-10

2.  Data smashing: uncovering lurking order in data.

Authors:  Ishanu Chattopadhyay; Hod Lipson
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

3.  How Much Does a Readmission Cost the Bundle Following Primary Hip and Knee Arthroplasty?

Authors:  Jessica L H Phillips; Alexander J Rondon; Chris Vannello; Yale A Fillingham; Matthew S Austin; P Maxwell Courtney
Journal:  J Arthroplasty       Date:  2019-01-23       Impact factor: 4.757

4.  Preoperative Frailty and Cognitive Dysfunction Assessment.

Authors:  Daniel S Rubin; Carol J Peden
Journal:  Anesthesiology       Date:  2020-12-01       Impact factor: 7.892

5.  New perspectives in the prediction of postoperative complications for high-risk ulcerative colitis patients: machine learning preliminary approach.

Authors:  L Sofo; P Caprino; C A Schena; F Sacchetti; A E Potenza; A Ciociola
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-12       Impact factor: 3.507

6.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

7.  Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events.

Authors:  Jennifer S Korsnes; Keith L Davis; Rinat Ariely; Christopher F Bell; Debanjali Mitra
Journal:  J Manag Care Spec Pharm       Date:  2015-06

Review 8.  Non-cardiac surgery in patients with valvular heart disease.

Authors:  Regina Sorrentino; Ciro Santoro; Luca Bardi; Vera Rigolin; Federico Gentile
Journal:  Heart       Date:  2022-07-13       Impact factor: 7.365

9.  Enhanced recovery program for hip and knee replacement reduces death rate.

Authors:  Ajay Malviya; Kate Martin; Ian Harper; Scott D Muller; Kevin P Emmerson; Paul F Partington; Mike R Reed
Journal:  Acta Orthop       Date:  2011-09-06       Impact factor: 3.717

10.  Use of Machine Learning to Develop and Evaluate Models Using Preoperative and Intraoperative Data to Identify Risks of Postoperative Complications.

Authors:  Bing Xue; Dingwen Li; Chenyang Lu; Christopher R King; Troy Wildes; Michael S Avidan; Thomas Kannampallil; Joanna Abraham
Journal:  JAMA Netw Open       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.